Dialogues in Cardiovascular Medicine - Vol 13 . N°4 . 2008



Drug-Eluting Stents in Angina




Percutaneous coronary intervention: a contemporary assessment
E. Braunwald




Drug-eluting coronary stents: stents and stent-ability
W. Wijns, M. Valgimigli



Medical therapy, surgery, or PCI: does (or should) the availability of drug-eluting stents influence the decision?
A. A. J. Adgey, B. M Glover, S. J. Walsh


Antiplatelet therapy: what to do if the patient with a drug-eluting stent needs elective noncardiac surgery?
M. Pfisterer, M. J. Zellweger, M. Filipovic, F. Nietlispach


What are the regulatory and economic challenges posed by drug-eluting stents?
B. R. Shah, K. A. Schulman




Matters @ Heart: Dr Patterson and his missing gene
R. J. Bing




M. Valgimigli


One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomised clinical trials
N. Mercado and others

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
C. Stettler and others

Clinical end points in coronary stent trials: a case for standardized definitions
D. E. Cutlip and others

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern
E. Camenzind and others

Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents
P. W. Serruys and J. Daemen
Drug-eluting stent update 2007: Part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Part II: Unsettled issues
J. Daemen and P. W. Serruys

Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with threevessel lumen obstruction undergoing percutaneous coronary intervention
M. Valgimigli and others

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
J. Daemen and others

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization
A. V. Finn and others

Balancing the risks of restenosis and stent thrombosis in baremetal versus drug-eluting stents. Results of a decision analytic model
P. Garg and others




© 2010 LES LABORATOIRES SERVIER, an incorporated company of SERVIER All Rights Reserved - Updates